Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction
- PMID: 15704523
- PMCID: PMC6654389
- DOI: 10.1002/clc.4960280102
Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction
References
-
- Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A, Ohman M, Granger CB, Van de Werf F, Simoons ML, O'Connor CM, Holmes DR: Frequency, patient characteristics, and outcomes of mild‐to‐moderate heart failure complicating ST‐segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials. Am Heart J 2003; 145: 73–79 - PubMed
-
- Steg PG, Dabbous OH, Feldman LJ, Cohen‐Solal A, Aumont MC, Lopez‐Sendon J, Budaj A, Goldberg RJ, Klein W, Anderson FA Jr, for the Global Registry of Acute Coronary Events Investigators : Determinants and prognostic impact of heart failure complicating acute coronary syndromes. Circulation 2004; 109: 494–499 - PubMed
-
- Wu AH, Parsons L, Every NR, Bates ER: Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction, a report from the Second National Registry of Myocardial Infarction. (NRMI‐2) J Am Coll Cardiol 2002; 40: 1389–1394 - PubMed
-
- Emanuelsson H, Karlson BW, Herlitz J: Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 1994; 15: 761–768 - PubMed
-
- Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309–1321 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical